Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-3-11
pubmed:abstractText
Ortho HCV Elisa Test System 2nd Generation and Abbott HCV EIA 2nd Generation tests were used in 293 sera collected from dialysis patients in order to determine the prevalence of anti-HCV in this risk group and the sensitivity of the two tests. The agreement between the two tests employed was 98.3%. All reactive sera were confirmed using Ortho Riba and Abbott Supplemental tests. 91.9% sera were confirmed positive by Ortho RIBA and 100% by Abbott Supplemental test. The anti-HCV prevalence in haemodialysis patients increased with age, duration of dialysis treatment and number of transfusions. Our study confirms the higher prevalence of anti-HCV in haemodialysis patients using 2nd generation tests and their specificity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0392-0623
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-22
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7679012-Adult, pubmed-meshheading:7679012-Age Factors, pubmed-meshheading:7679012-Aged, pubmed-meshheading:7679012-Alanine Transaminase, pubmed-meshheading:7679012-Blood Transfusion, pubmed-meshheading:7679012-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:7679012-Female, pubmed-meshheading:7679012-Hepacivirus, pubmed-meshheading:7679012-Hepatitis Antibodies, pubmed-meshheading:7679012-Hepatitis C, pubmed-meshheading:7679012-Hepatitis C Antibodies, pubmed-meshheading:7679012-Humans, pubmed-meshheading:7679012-Male, pubmed-meshheading:7679012-Middle Aged, pubmed-meshheading:7679012-Prevalence, pubmed-meshheading:7679012-Recombinant Proteins, pubmed-meshheading:7679012-Renal Dialysis, pubmed-meshheading:7679012-Sensitivity and Specificity, pubmed-meshheading:7679012-Time Factors
pubmed:year
1993
pubmed:articleTitle
Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
pubmed:affiliation
Istituto Policattedra Clinica Medica e Malattie Infettive, Università di Bari, Italy.
pubmed:publicationType
Journal Article, Comparative Study